Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults
Top Cited Papers
Open Access
- 1 May 2003
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 348 (18), 1747-1755
- https://doi.org/10.1056/nejmoa022678
Abstract
Streptococcus pneumoniae is the chief cause of pneumonia in older adults, but it remains unclear whether use of the pneumococcal polysaccharide vaccine alters the overall risk of community-acquired pneumonia. In a large population of older adults, we assessed the effectiveness of the pneumococcal vaccine.Keywords
This publication has 29 references indexed in Scilit:
- Hospitalized Community-acquired Pneumonia in the ElderlyAmerican Journal of Respiratory and Critical Care Medicine, 2002
- The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung DiseaseArchives of Internal Medicine, 1999
- Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or olderVaccine, 1999
- Is Streptococcus Pneumoniae the leading cause of pneumonia of unknown etiology? a microbiologic study of lung aspirates in consecutive patients with community-acquired pneumoniaAmerican Journal Of Medicine, 1999
- Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly peopleThe Lancet, 1998
- Clinical Efficacy of Pneumococcal Vaccine in the ElderlyAmerican Journal Of Medicine, 1997
- Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study GroupArchives of Internal Medicine, 1997
- Community-Acquired PneumoniaNew England Journal of Medicine, 1995
- Community-Acquired Pneumonia Requiring Hospitalization: 5-Year Prospective StudyClinical Infectious Diseases, 1989
- Efficacy of Pneumococcal Vaccine in High-Risk PatientsNew England Journal of Medicine, 1986